Statin use, HMGCR expression, and breast cancer survival – The Malmö Diet and Cancer Study

Statins, commonly used to treat hypercholesterolemia, have also been proposed as anti-cancer agents. The identification of a predictive marker is essential. The 3-hydroxy-3-methylglutaryl-coenzyme-A reductase (HMGCR), which is inhibited by statins, might serve as such a marker. Thorough antibody val...

Descripción completa

Detalles Bibliográficos
Autores principales: Bjarnadottir, Olöf, Feldt, Maria, Inasu, Maria, Bendahl, Pär-Ola, Elebro, Karin, Kimbung, Siker, Borgquist, Signe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969108/
https://www.ncbi.nlm.nih.gov/pubmed/31953433
http://dx.doi.org/10.1038/s41598-019-57323-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969108/
https://www.ncbi.nlm.nih.gov/pubmed/31953433
http://dx.doi.org/10.1038/s41598-019-57323-9

Ejemplares similares